EGFR Antibodies

Santa Cruz Biotechnology features a diverse variety of EGFR monoclonal antibodies for investigating epidermal growth factor receptor (EGFR) signaling pathways. EGFR Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EGFR plays a central role in cell proliferation, differentiation, and survival, making it essential in various physiological processes and cancer development. Dysregulation of EGFR signaling is associated with numerous malignancies, highlighting its significance in cancer research and therapeutic development. Understanding EGFR function can lead to the identification of novel therapeutic targets and improve treatment strategies for patients with EGFR-related diseases. EGFR monoclonal antibodies enable precise detection and analysis of EGFR expression patterns across different cell types and tissues. Researchers can explore cellular responses to growth factors and investigate downstream signaling cascades with reliable results. EGFR monoclonal antibodies from Santa Cruz Biotechnology support scientists worldwide in advancing our understanding of cancer biology and developing targeted therapies.